Archive for June, 2002

Cracking the cancer code

Cracking the cancer code Whether a tumor invades the lung or breast is beside the point. Its genetic activity will dictate how to attack it


Click here for reuse options!
Copyright 2002 Biotechblog

Report raps drug firms' 'post-approval' studies

Report raps drug firms’ ‘post-approval’ studies Drug manufacturers spent $1.5 billion in 2000 to test medicines already approved by the Food and Drug Administration primarily so they could make new marketing claims to sell their products, industry specialists said this week. Critics say the trend inflates health care costs while undercutting the integrity of research.


Click here for reuse options!
Copyright 2002 Biotechblog

Report raps drug firms’ ‘post-approval’ studies

Report raps drug firms’ ‘post-approval’ studies Drug manufacturers spent $1.5 billion in 2000 to test medicines already approved by the Food and Drug Administration primarily so they could make new marketing claims to sell their products, industry specialists said this week. Critics say the trend inflates health care costs while undercutting the integrity of research.


Click here for reuse options!
Copyright 2002 Biotechblog

5 Big Drug Companies Face R&D Drought

5 Big Drug Companies Face R&D Drought Five of the world’s biggest drug companies do not have any potential billion-dollar drugs in late-stage development, highlighting the industry’s current poor R&D productivity, according to a report released on Wednesday.


Click here for reuse options!
Copyright 2002 Biotechblog

5 Big Drug Companies Face R&D Drought

5 Big Drug Companies Face R&D Drought Five of the world’s biggest drug companies do not have any potential billion-dollar drugs in late-stage development, highlighting the industry’s current poor R&D productivity, according to a report released on Wednesday.


Click here for reuse options!
Copyright 2002 Biotechblog

%d bloggers like this: